Fig. 5From: Development of a necroptosis-related gene signature and the immune landscape in ovarian cancerVerification of prognosis gene signature. (A) Uni-Cox analysis of clinicopathologic features and the risk score for OS. (B) Multi-Cox analysis of clinicopathologic features and the risk score for OS. (C) The ROC curves for 1-, 3- and 5-year OS. (D) The ROC curves for the 5-year OS of risk score and the other clinical features. (E) The C-index curves of risk score and the other clinical features. (F) Nomogram for predicting overall survival. (G) The calibration curves for 1-, 3- and 5-year OSBack to article page